Milam 7.5mg tablets contain the active ingredient midazolam, a short-acting medication belonging to the benzodiazepine drug class. In Kenya, it is classified as a controlled prescription-only medication under the Pharmacy and Poisons Board regulations.
Primary Medical Uses
Milam 7.5mg works by enhancing the activity of GABA (a calming chemical in the brain) to provide rapid sedative, muscle-relaxant, and anti-anxiety effects. Doctors primarily prescribe it for:
-
Short-term management of severe insomnia: Used at bedtime for individuals experiencing acute sleep disturbances.
-
Preoperative sedation (Premedication): Administered shortly before surgical or diagnostic procedures (like endoscopies) to reduce anxiety and induce relaxation or light sleep.
Administration Guidelines
-
Adults: The medication is typically taken immediately before bedtime or before a planned medical procedure.
-
Elderly or Debilitated Patients: Cautious and reduced amounts are typically evaluated by healthcare providers for older adults, as they are far more sensitive to the sedative effects, increasing their risk of confusion or falls.
-
Administration Note: Tablets must be swallowed whole with water and should never be crushed or chewed.
Critical Safety Risks & Side Effects
Because it is a potent sedative, midazolam carries significant clinical warnings:
-
Respiratory Depression: The most severe risk is a dangerous slowing or stopping of breathing, particularly if combined with alcohol, opioids, or other sleep aids.
-
Common Side Effects: Daytime drowsiness, dizziness, muscle weakness, fatigue, and temporary short-term memory gaps (anterograde amnesia).
-
Dependence and Tolerance: Milam is strictly intended for short-term use only. Taking it for extended periods can cause physical dependence and severe rebound insomnia or anxiety upon stopping.
-
Pregnancy Warning: This medication crosses the placenta and should generally be avoided during pregnancy unless explicitly deemed life-saving by a physician, as it can cause breathing issues and withdrawal symptoms in newborns.
